To help clinicians and patients obtain better information about the breast or ovarian cancer risks posed by specific mutations in the BRCA1 gene, Greg Findlay, an M.D./Ph.d.
For the first time, scientists have created, entirely from scratch, a protein capable of binding to a small target molecule.
Protein assemblies, designed and built from scratch to carry molecular cargo, are advancing both synthetic life research and engineering efforts for targeted drug delivery.
The same 20-sided solid that was morphed into geodesic domes in the past century may be the shape of things to come in synthetic biology.
GeekWire reports the news that biochemists at th